Dishman Carbogen Amcis Faces Declining Stock Performance Amid Broader Market Trends

Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant stock activity today, reflecting broader market trends. The company's market capitalization stands at Rs 3,189.00 crore, with a price-to-earnings (P/E) ratio of -30.44, notably lower than the industry average of 35.75.
Over the past year, Dishman Carbogen Amcis has seen a decline of 17.03%, contrasting sharply with the Sensex, which has gained 7.73% during the same period. Today's performance shows a drop of 5.28%, while the Sensex has only slightly decreased by 0.06%. In the last week, the stock has fallen by 7.73%, compared to a modest 0.16% increase in the Sensex.

Looking at longer-term trends, the stock's year-to-date performance is down 28.87%, while the Sensex has risen by 2.69%. Over three years, Dishman Carbogen Amcis has gained 16.78%, but this is significantly lower than the Sensex's 40.63% increase. In the five-year span, the stock has appreciated by 130.84%, yet it still trails the Sensex's 137.98% growth. Technical indicators suggest a bearish sentiment in both weekly and monthly assessments.